HIV and AIDS

This article examines the ongoing challenge of rising HIV infections in the United States and its implications for ending the epidemic. Despite over 40 years of scientific and medical advancements—including widespread access to antiretroviral therapy (ART), single-pill regimens, long-acting injectables, and pre-exposure prophylaxis (PrEP)—new HIV infections remain disproportionately high among Black and Latine communities.

This study describes the development and implementation of a comprehensive HIV co-testing initiative across Intermountain Health’s urgent care clinics and emergency departments. The program was designed to standardize HIV screening for patients undergoing evaluation for sexually transmitted infections, addressing historically low HIV testing rates in Utah. Key components included clinician and patient education, electronic health record alerts prompting HIV test orders when appropriate, and a structured link-to-care system to ensure rapid follow-up for newly diagnosed individuals.

The “Aging With HIV Cheat Sheet” provides practical, research-informed guidance for people living with HIV who are growing older — reflecting that many people with HIV now live well into middle age and beyond. It recognizes that as people with HIV age, their health needs evolve — combining general aging challenges with HIV-specific risks. 
Why aging with HIV matters more now:
•    In the U.S., more than half of people living with HIV are now aged 50 or older.

This article provides a comprehensive overview of pre-exposure prophylaxis (PrEP), a highly effective HIV prevention medication for people who are HIV-negative and at increased risk of acquiring the virus. It explains that when taken as prescribed, PrEP reduces HIV transmission risk by about 99%, making the chance of contracting HIV from someone correctly using PrEP extremely low.

This report provides an overview of high-risk HIV behaviors among women ages 18–44 in the United States, based on national surveillance data from the Behavioral Risk Factor Surveillance System (BRFSS). High-risk behaviors include injecting non-prescribed drugs, receiving treatment for a sexually transmitted infection, and exchanging sex for money or drugs within the past year. These behaviors are key indicators of HIV vulnerability and often reflect broader social and structural factors such as access to health care, substance use patterns, and economic instability.

This webinar features a presentation from the March 2024 Conference on Retroviruses and Opportunistic Infections (CROI), where Dr. Patrick Sullivan—AIDSVu Principal Scientist and Professor at Emory University—presented the oral abstract, “Association of State-Level PrEP Coverage and State-Level HIV Diagnoses, US, 2012–2021.” Using real-world data on PrEP coverage, Dr. Sullivan’s study found that states with a higher proportion of people with PrEP indications who were using PrEP experienced steeper declines in new HIV diagnoses over the past decade.

This video educates viewers on what the PrEP-to-Need Ratio is and how to properly use it to evaluate health equity.

This video walks through AIDSVu Location Profiles -- interactive, user-friendly summaries of HIV data for various locations across the U.S., including cities, counties, states, and regions. These profiles provide insights into HIV prevalence, new diagnoses, mortality, and more, helping users understand the impact of HIV in their communities.

This toolkit is organized into flexible, standalone sections to meet the varied needs of Title X and SRH providers. You do not need to use the toolkit in order. The toolkit is organized by types of PrEP services so that the user can identify and access the tools and resources most relevant to the services provided in their setting. Whether you provide counseling and referrals or deliver the full spectrum of services onsite, the materials here are designed to support your work.

This webpage outlines the importance of disaster preparedness for people with HIV. Natural disasters—such as hurricanes, tornadoes, tsunamis, and wildfires—can displace anyone, disrupting access to critical HIV medicines and care. It emphasizes the need for individuals with HIV to plan ahead to maintain treatment continuity, protect their health, and reduce the risk of transmission, including steps to connect with new healthcare providers if displaced.